Back to mobile site

SpyGlass Pharma buys AVS from Santen for $13 million

October 1, 2026 8:02 AM EDT Send to a Friend
SpyGlass Pharma, Inc. (Nasdaq: SGP) announced the acquisition of Advanced Vision Science, Inc. (AVS), a California-based intraocular lens (IOL) manufacturer ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login